Abstract:Introduction: Beta-amyloid accumulation in the brain appears to be a key initiating event in Alzheimer's disease (AD), and factors associated with increased deposition of beta-amyloid are of great interest. Enhanced deposition of amyloid-β peptides is due to an imbalance between their production and elimination. Previous studies show that diminished levels of CSF amyloid beta 42 (Aβ42) is a biomarker in AD; however, the role of serum Aβ42 in AD is contradictory. BMI and obesity have been reported to be related to increased serum Aβ42 levels. Therefore, we aimed to investigate the relation between metabolic syndrome (MetS), its clinical measures (abdominal obesity, high glucose, high triglyceride, low high-density lipoprotein cholesterol level, and hypertension), and serum Aβ42 levels. Methods: A total of 1261 subjects, aged 18–89 years in Chengdu, China, were enrolled from January 2020 to January 2021 to explore the correlation of serum Aβ42 levels with body mass index (BMI), blood lipids, and blood pressure. Furthermore, as the risk of MetS is closely related to age, 1,212 participants ( N = 49 with age ≥ 80 years old were excluded) were analyzed for the correlation of serum Aβ42 level and MetS clinical measures. Results: The results showed that log-transformed serum Aβ42 level was positively correlated with BMI ( R = 0.29; p < 0.001), log-transformed triglyceride ( R = 0.14; p < 0.001), and diastolic blood pressure (DBP) ( R = 0.12; p < 0.001) and negatively correlated with high-density lipoprotein (HDL-c) ( R = −0.18; p < 0.001). After adjusting for age, sex, and other covariates, elevated serum Aβ42 level was correlated with higher values of BMI (βmodel1 = 2.694, βmodel2 = 2.703) and DBP (βmodel1 = 0.541, βmodel2 = 0.546) but a lower level of HDL-c (βmodel2 = −1.741). Furthermore, serum Aβ42 level was positively correlated with MetS and its clinical measures, including BMI and DBP, and negatively correlated with HDL-c level in the Han Chinese population. However, the level of serum Aβ42 did not show a significant correlation with high glucose or high triglyceride. Discussion: These observations indicate that MetS and its components are associated with higher levels of serum Aβ42 and hence limit the potential of serum Aβ42 as a suitable diagnostic biomarker for AD. As such, we recommend serum Aβ42 serve as a direct risk biomarker for MetS rather than for AD.

Serum Apolipoprotein B is Associated with Increased Risk of Metabolic Syndrome among Middle‐aged and Elderly Chinese: A Cross‐sectional and Prospective Cohort Study

The value of the apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio in predicting carotid atherosclerosis among Chinese individuals with metabolic syndrome: a cross-sectional study

The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study

Change of serum uric acid and progression of cardiometabolic multimorbidity among middle aged and older adults: A prospective cohort study

Association Between Baseline and Changes in Serum Uric Acid and Incident Metabolic Syndrome: a Nation-Wide Cohort Study and Updated Meta-Analysis.

Association Of Serum Bile Acids With Metabolic Syndrome In A Chinese Population

Serum Apob Levels Independently Predict the Development of Non-Alcoholic Fatty Liver Disease: A 7-Year Prospective Study

Associations of Fine Particulate Matter Constituents with Metabolic Syndrome and the Mediating Role of Apolipoprotein B: A Multicenter Study in Middle-Aged and Elderly Chinese Adults

The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study

Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese

Low Serum Total Bilirubin Concentrations Are Associated with Increased Prevalence of Metabolic Syndrome in Chinese

Association of serum BPA levels with changes in lipid levels and dyslipidemia risk in middle-aged and elderly Chinese

Serum Fetuin-a is Correlated with Metabolic Syndrome in Middle-Aged and Elderly Chinese.

Association of apolipoprotein B with all-cause and cardiovascular mortality among adults: Results from the National Health and Nutrition Examination Surveys

The association of apolipoprotein B with chronic kidney disease in the Chinese population

Gonadal hormones and metabolic syndrome in middle-aged and elderly males: results from a prospective cohort study in China

Prevalence of metabolic syndrome among middle-aged and elderly adults in China: current status and temporal trends

Serum amyloid beta 42 levels correlated with metabolic syndrome and its components

Association of the serum uric acid to creatinine ratio with metabolic syndrome in the middle age and older population in China

Relations of body weight status in early adulthood and weight changes until middle age with metabolic syndrome in the Chinese population

Impact of the Serum Uric Acid Level on Subclinical Atherosclerosis in Middle-aged and Elderly Chinese.